{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T19:30:29Z","timestamp":1773516629658,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,1,16]],"date-time":"2006-01-16T00:00:00Z","timestamp":1137369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,1,16]],"date-time":"2006-01-16T00:00:00Z","timestamp":1137369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.1038\/sj.bmt.1705266","type":"journal-article","created":{"date-parts":[[2006,1,16]],"date-time":"2006-01-16T08:29:15Z","timestamp":1137400155000},"page":"367-372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Autologous stem cell transplantation in elderly (>60 years) patients with non-Hodgkin's lymphoma: a nation-wide analysis"],"prefix":"10.1038","volume":"37","author":[{"given":"E","family":"Jantunen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"It\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Juvonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Lepp\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Keskinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Vasala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Remes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Wiklund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Elonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Nousiainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,1,16]]},"reference":[{"key":"BF1705266_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3109\/10428199309145876","volume":"10","author":"PR Goss","year":"1993","unstructured":"Goss PR . Non-Hodgkin's lymphoma in elderly patients. Leuk Lymphoma 1993; 10: 147\u2013156.","journal-title":"Leuk Lymphoma"},{"key":"BF1705266_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1200\/JCO.1986.4.3.295","volume":"4","author":"DO Dixon","year":"1986","unstructured":"Dixon DO, Neilan B, Jones SE, Lipschitz DA, Miller TP, Grozea PA et al. Effect of age on therapeutic outcome in advanced histiocytic lymphoma. J Clin Oncol 1986; 4: 295\u2013305.","journal-title":"J Clin Oncol"},{"key":"BF1705266_CR3","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1200\/JCO.1988.6.12.1838","volume":"6","author":"JM Vose","year":"1988","unstructured":"Vose JM, Armitage JO, Weisenburger DD, Bierman PJ, Sorensen S, Hutchins M et al. The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma. J Clin Oncol 1988; 6: 1838\u20131844.","journal-title":"J Clin Oncol"},{"key":"BF1705266_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235\u2013242.","journal-title":"N Engl J Med"},{"key":"BF1705266_CR5","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1182\/blood-2003-06-2095","volume":"104","author":"M Pfreundschuh","year":"2004","unstructured":"Pfreundschuh M, Trumper L, Kloess M, Schmits R, Feller AC, Rube C et al. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. Blood 2004; 104: 634\u2013641.","journal-title":"Blood"},{"key":"BF1705266_CR6","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A, Somers R, van der Lelie H, Bron D et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540\u20131545.","journal-title":"N Engl J Med"},{"key":"BF1705266_CR7","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa031770","volume":"350","author":"N Milpied","year":"2004","unstructured":"Milpied N, Deconinck E, Gaillard F, Delwail V, Foussard C, Berthou C et al. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 2004; 350: 1287\u20131295.","journal-title":"N Engl J Med"},{"key":"BF1705266_CR8","doi-asserted-by":"publisher","first-page":"6a","DOI":"10.1182\/blood-2004-04-1495","volume":"104","author":"C Geisler","year":"2004","unstructured":"Geisler C, Elonen E, Kolstad A, Laurell A, Andersen NS, Pedersen L et al. Nordic Mantle Cell Lymphoma (MCL) Project: Prolonged follow-up of 86 patients treated with BEAM\/BEAC+PBSCT confirm that addition of high-dose AraC and rituximab to CHOP induction+in vivo purging with rituximab increases clinical and molecular response rates, pcr-negative grafts, failure-free, relapse-free and overall survival. Blood 2004; 104: 6a (abstr).","journal-title":"Blood"},{"key":"BF1705266_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.bmt.1700833","volume":"20","author":"SC Guba","year":"1997","unstructured":"Guba SC, Vesole DH, Jagannath S, Bracy D, Barlogie B, Tricot G . Peripheral stem cell mobilization and engraftment in patients over age 60. Bone Marrow Transplant 1997; 20: 1\u20133.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705266_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/sj.bmt.1700604","volume":"19","author":"A Stamatoullas","year":"1997","unstructured":"Stamatoullas A, Fruchart C, Khalfallah S, Buchonnet G, Contentin N, Bastit D et al. Peripheral blood stem cell transplantation for relapsed or refractory aggressive lymphoma in patients over 60 years of age. Bone Marrow Transplant 1997; 19: 31\u201335.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705266_CR11","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/sj.bmt.1701272","volume":"21","author":"P Moreau","year":"1998","unstructured":"Moreau P, Milpied N, Voillat L, Colombat P, Mahe B, Rapp MJ et al. Peripheral blood stem cell transplantation as front-line therapy in patients aged 61\u201365 years: a pilot study. Bone Marrow Transplant 1998; 21: 1193\u20131196.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705266_CR12","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/sj.bmt.1701804","volume":"23","author":"P Mazza","year":"1999","unstructured":"Mazza P, Palazzo G, Amurri B, Cervellera M, Manna N, Fellini G et al. Analysis of feasibility of myeloablative therapy and autologous peripheral stem cell (PBSC) transplantation in the elderly: an interim report. Bone Marrow Transplant 1999; 23: 1273\u20131278.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705266_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/sj.bmt.1702577","volume":"26","author":"E Jantunen","year":"2000","unstructured":"Jantunen E, Mahlam\u00e4ki E, Nousiainen T . Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (>60 years) with non-Hodgkin's lymphoma: comparison with patients <60 years treated within the same protocol. Bone Marrow Transplant 2000; 26: 737\u2013741.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705266_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S1083-8791(00)70044-9","volume":"6","author":"CS Leger","year":"2000","unstructured":"Leger CS, Bredeson C, Kearns B, Bence-Bruckler I, Atkins H, Huebsch L . Autologous blood and marrow transplantation in patients 60 years and older. Biol Blood Marrow Transplant 2000; 6: 204\u2013210.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705266_CR15","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/sj.bmt.1703034","volume":"27","author":"A Olivieri","year":"2001","unstructured":"Olivieri A, Capelli D, Montanari M, Brunori M, Massidda D, Poloni A et al. Very low toxicity and good quality of life in 48 elderly patients autotransplanted for haematological malignancies: a single centre experience. Bone Marrow Transplant 2001; 27: 1189\u20131195.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705266_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s00277-002-0492-1","volume":"81","author":"F Zallio","year":"2002","unstructured":"Zallio F, Cuttica A, Caracciolo D, Gavarotti P, Bergui L, Giaretta F et al. Feasibility of peripheral blood progenitor cell mobilisation and harvest to support chemotherapy intensification in elderly patients with poor prognosis non-Hodgkin's lymphoma. Ann Hematol 2002; 81: 448\u2013453.","journal-title":"Ann Hematol"},{"key":"BF1705266_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1083-8791(03)00099-5","volume":"9","author":"JD Bitran","year":"2003","unstructured":"Bitran JD, Klein L, Link D, Kosirog-Glowacki J, Stewart C, Raack D et al. High-dose myeloablative therapy and autologous peripheral blood progenitor cell transplantation for elderly patients (greater than 65 years of age) with relapsed large cell lymphoma. Biol Blood Marrow Transplant 2003; 9: 383\u2013388.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705266_CR18","first-page":"300","volume":"88","author":"L Villela","year":"2003","unstructured":"Villela L, Sureda A, Canals C, Sanz Jr MA, Martino R, Valcarcel D et al. Low transplant-related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation. Haematologica 2003; 88: 300\u2013305.","journal-title":"Haematologica"},{"key":"BF1705266_CR19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/sj.bmt.1702833","volume":"27","author":"AK Gopal","year":"2001","unstructured":"Gopal AK, Gooley TA, Golden JB, Maloney DG, Bensinger WI, Petersdorf SH et al. Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older. Bone Marrow Transplant 2001; 27: 593\u2013599.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705266_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.bmt.1702736","volume":"27","author":"J de la Rubia","year":"2001","unstructured":"de la Rubia J, Saavedra S, Sanz GF, Martin G, Moscardo F, Martinez J et al. Transplant-related mortality in patients older than 60 years undergoing autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 21\u201325.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705266_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1034\/j.1600-0609.2003.00093.x","volume":"71","author":"NS Andersen","year":"2003","unstructured":"Andersen NS, Pedersen L, Elonen E, Johnson A, Kolstad A, Franssila K et al. for the Nordic Lymphoma Group. Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant. Eur J Haematol 2003; 71: 73\u201380.","journal-title":"Eur J Haematol"},{"key":"BF1705266_CR22","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1046\/j.1365-2141.2003.04140.x","volume":"120","author":"E Vandenberghe","year":"2003","unstructured":"Vandenberghe E, Ruiz de Elvira C, Loberiza FR, Conde E, Lopez-Guillermo A, Gisselbrecht C et al. Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Marrow Transplant and Autologous Blood and Marrow Transplant Registries. Br J Haematol 2003; 120: 793\u2013800.","journal-title":"Br J Haematol"},{"key":"BF1705266_CR23","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1182\/blood-2004-10-3883","volume":"105","author":"M Dreyling","year":"2005","unstructured":"Dreyling M, Lenz G, Hoster E, Van Hoof A, Gisselbrecht C, Schmits R et al. Early consolidation with myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle cell lymphoma: results of a prospective randomized trial of the European MCL Network. Blood 2005; 105: 2677\u20132684.","journal-title":"Blood"},{"key":"BF1705266_CR24","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1200\/JCO.1996.14.2.534","volume":"14","author":"M Martelli","year":"1996","unstructured":"Martelli M, Vignetti M, Zinzani PL, Cherlinzoni F, Meloni G, Fiacchini M et al. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front line chemotherapy: a prospective randomized Italian multicenter study. J Clin Oncol 1996; 14: 534\u2013542.","journal-title":"J Clin Oncol"},{"key":"BF1705266_CR25","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1200\/JCO.1996.14.2.586","volume":"14","author":"R Pettengell","year":"1996","unstructured":"Pettengell R, Radford JA, Morgenstern GR, Scarffe JH, Harris M, Woll PJ et al. Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma. J Clin Oncol 1996; 14: 586\u2013592.","journal-title":"J Clin Oncol"},{"key":"BF1705266_CR26","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1200\/JCO.1997.15.3.1131","volume":"15","author":"C Haioun","year":"1997","unstructured":"Haioun C, Lepage E, Gisselbrecht C, Bastion Y, Coiffier B, Brice P et al. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective LNH 87-2. J Clin Oncol 1997; 15: 1131\u20131137.","journal-title":"J Clin Oncol"},{"key":"BF1705266_CR27","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1056\/NEJM199705013361804","volume":"336","author":"AM Gianni","year":"1997","unstructured":"Gianni AM, Bregni M, Siena S, Brambilla C, Di Nicola M, Lombardi F et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 1997; 336: 1290\u20131297.","journal-title":"N Engl J Med"},{"key":"BF1705266_CR28","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJM199504203321601","volume":"332","author":"LF Verdonck","year":"1995","unstructured":"Verdonck LF, van Putten WLJ, Hagenbeek A, Schouten HC, Sonnevelt P, van Imhoff GW et al. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N Engl J Med 1995; 332: 1045\u20131051.","journal-title":"N Engl J Med"},{"key":"BF1705266_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/jnci\/93.1.22","volume":"93","author":"HC Kluin-Nelemans","year":"2001","unstructured":"Kluin-Nelemans HC, Zagonel V, Anastasopoulou A, Bron D, Roozendaal KJ, Noordjik FM et al. Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomised phase III EORTC study. J Natl Cancer Inst 2001; 93: 22\u201330.","journal-title":"J Natl Cancer Inst"},{"key":"BF1705266_CR30","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1200\/JCO.2002.02.125","volume":"20","author":"C Gisselbrecht","year":"2002","unstructured":"Gisselbrecht C, Lepage E, Molina T, Quesnel B, Fillet G, Lederlin P et al. Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma. J Clin Oncol 2002; 20: 2472\u20132479.","journal-title":"J Clin Oncol"},{"key":"BF1705266_CR31","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1200\/JCO.2002.07.075","volume":"20","author":"U Kaiser","year":"2002","unstructured":"Kaiser U, Uebelacker I, Abel U, Birkmann J, Trumper L, Schmalenberg H et al. Randomized study to evaluate the use of high-dose therapy as a part of primary treatment for \u2018aggressive\u2019 lymphoma. J Clin Oncol 2002; 20: 4413\u20134419.","journal-title":"J Clin Oncol"},{"key":"BF1705266_CR32","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1200\/JCO.2003.01.117","volume":"21","author":"M Martelli","year":"2003","unstructured":"Martelli M, Gherlinzoni F, De Renzo A, Zinzani PL, De Vivo A, Contonetti M et al. Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial. J Clin Oncol 2003; 21: 1255\u20131262.","journal-title":"J Clin Oncol"},{"key":"BF1705266_CR33","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1056\/NEJMoa040125","volume":"351","author":"R Spielberger","year":"2004","unstructured":"Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004; 351: 2590\u20132598.","journal-title":"N Engl J Med"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705266","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705266.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705266.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:10:02Z","timestamp":1648080602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,16]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,2,1]]}},"alternative-id":["BF1705266"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705266","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,16]]},"assertion":[{"value":"30 September 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2005","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}